RT @CD_AACR: ICYMI— In celebration of the journal's 10th Anniversary, we're highlighting articles published in the past decade: Not All BRA…
RT @CD_AACR: ICYMI— In celebration of the journal's 10th Anniversary, we're highlighting articles published in the past decade: Not All BRA…
ICYMI— In celebration of the journal's 10th Anniversary, we're highlighting articles published in the past decade: Not All BRAF-Mutant Cancers Are Created Equal. #CDturns10 https://t.co/1k2yVi3bAH Read the article from the March 2012 issue: https://t.co
RT @ElizSMcKenna: Ryan Corcoran @MGHCancerCenter talking now at #AACR20 about his classic 2012 @CD_AACR paper about EGFR mediating resistan…
RT @ElizSMcKenna: And history now repeating itself with KRAS inhibitors in CRC - #AACR20 @Sandra_Misale @Albert0Bardelli @BardelliLab http…
RT @ElizSMcKenna: And history now repeating itself with KRAS inhibitors in CRC - #AACR20 @Sandra_Misale @Albert0Bardelli @BardelliLab http…
And history now repeating itself with KRAS inhibitors in CRC - #AACR20 @Sandra_Misale @Albert0Bardelli @BardelliLab https://t.co/oBmmI4IDtv
Ryan Corcoran @MGHCancerCenter talking now at #AACR20 about his classic 2012 @CD_AACR paper about EGFR mediating resistance to BRAF inhibition in colorectal cancer https://t.co/T5qbZw938l
@pashtoonkasi @skopetz @agrothey @NEJM Exactly!! Seems very similar - everything coming full circle! https://t.co/T5qbZw938l
RC: describes work from Corcoran et al 2012 that suggests EGFR drives MAPK reactivation and BRAF resistance http://t.co/fz491UXIeM #ENA2014